Evidence map›Paper›PMID 28565827›Full record

ArticleExperimental and therapeutic medicine2017

Neuroprotective effect of combining tanshinone IIA with low-dose methylprednisolone following acute spinal cord injury in rats.

Nian-Wei Yao, Yuan Lu, Li-Qi Shi, Feng Xu, Xian-Hua Cai

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Danshen (Frontiers in pharmacology · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nian-Wei YaoDepartment of Orthopedics, The Third Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu 210000, P.R. China.
Yuan LuDepartment of Neurology, Nantong First People's Hospital, Nantong, Jiangsu 226000, P.R. China.
Li-Qi ShiDepartment of Orthopedics, Yuyao Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang 315000, P.R. China.
Feng XuDepartment of Orthopedics, Wuhan General Hospital of Guangzhou Military Command, Wuhan, Hubei 430070, P.R. China.
Xian-Hua CaiDepartment of Orthopedics, Wuhan General Hospital of Guangzhou Military Command, Wuhan, Hubei 430070, P.R. China.
Wuhan General Hospital of Guangzhou · CNNanjing Traditional Chinese Medicine Hospital · CNSecond People's Hospital of NanTong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study compared the potential neuroprotective effect of tanshinone IIA (TIIA) monotherapy, methylprednisolone (MP) monotherapy and combined treatment in an adult acute spinal cord injury (ASCI) rat model. The current study used the weight-drop method (Allen's Impactor) in the rat model and the mechanical scratch method in primary spinal cord neuron culture to determine whether the combined treatment was able to reduce the required dosage of MP in the treatment of ASCI to produce a similar or improved therapeutic effect.

Indexed as

acute spinal cord injuryanti-apoptoticanti-inflammatoryapoptosis factorsmethylprednisolonetanshinone IIA

Identifiers

PMID28565827
PMCPMC5443198
OpenAlexW2601494682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.